

Table of Contents
ToggleThe ASEAN Cosmetic Claim Guidelines form the regulatory backbone for any company involved in manufacturing, importing, or distributing cosmetics in Southeast Asia. Issued under the ASEAN Cosmetic Directive (ACD) by the Association of Southeast Asian Nations, these guidelines determine whether a product qualifies as a cosmetic and specify which claims are legally acceptable. For businesses conducting cosmetic product notification in Vietnam, understanding these claim requirements is especially critical, as non-compliant wording can result in notification rejection, product reclassification, or regulatory penalties.
In this article, Green NRJ will provide a comprehensive analysis of the ASEAN framework, explain the 5-step decision process for claim assessment, and outline practical strategies to ensure full cosmetic claim compliance across ASEAN markets.
The ASEAN Cosmetic Directive (ACD) was developed to harmonize cosmetic regulations among ASEAN Member States. Its objective is to facilitate trade while ensuring consumer safety and preventing misleading marketing practices.
Appendix III of the ASEAN Cosmetic Documents — known as the ASEAN Cosmetic Claim Guidelines — plays a decisive role in product classification. In ASEAN markets, claim evaluation is inseparable from determining whether a product is legally a cosmetic. A product may have a compliant formula, but if its claims imply therapeutic or medicinal effects, it may fall outside the cosmetic scope and become subject to pharmaceutical regulation.
Therefore, understanding cosmetic claim compliance in ASEAN is not simply a marketing matter — it is a regulatory obligation.
Rather than offering an isolated checklist, the Guidelines establish a logical decision-making framework. Each step builds upon the previous one to assess whether a product and its claims remain within the cosmetic definition.

The evaluation begins with the product’s formulation. A cosmetic must contain only ingredients permitted under the ACD Annexes and must not include any substances listed as banned.
This step ensures baseline safety compliance. However, ingredient conformity alone does not guarantee cosmetic classification. Even a fully compliant formula can face regulatory challenges if its claims exceed cosmetic boundaries.
For companies pursuing ASEAN cosmetic product registration, formulation review and claims review must be conducted simultaneously to prevent regulatory rejection.
The second layer of assessment focuses on the intended site of application. Under the ASEAN Cosmetic Directive, a cosmetic product must be designed for contact with specific external parts of the human body, including the epidermis (skin), hair system, nails, lips, external genital organs, as well as the teeth and the mucous membranes of the oral cavity. This definition clearly excludes products intended for ingestion, injection, or internal application, such as those targeting the nasal passages or internal genitalia. When a product goes beyond these externally applied areas, it may no longer qualify as a cosmetic under ASEAN law and could fall under a different regulatory framework. This distinction is especially significant for innovative or hybrid products that blur the boundaries between cosmetics, medical devices, and pharmaceuticals, where classification determines the applicable compliance pathway.
At the core of the ASEAN Cosmetic Claim Guidelines is the product’s primary intended function. To qualify as a cosmetic under the ASEAN Cosmetic Directive, a product must be applied exclusively or mainly to clean, perfume, change appearance, correct body odor, protect, or keep the body in good condition. The regulatory emphasis is clearly placed on maintenance and enhancement of external features rather than on the treatment, prevention, or cure of disease.
That said, the Guidelines acknowledge that certain products may carry minor secondary functions that extend slightly beyond these principal purposes. References to concerns such as dandruff, acne, cellulite, or hair loss may be acceptable, provided the wording remains cosmetic in nature and does not suggest therapeutic or medicinal action. In this context, language precision becomes legally critical. For example, stating that a product “helps reduce the appearance of acne” maintains a cosmetic positioning, whereas claiming that it “treats acne” implies medical efficacy and may trigger product reclassification under a stricter regulatory regime.
ASEAN regulators do not assess cosmetic claims in isolation; instead, they evaluate the overall presentation of the product to consumers. This holistic review covers label wording, packaging graphics, inserts and informational leaflets, promotional materials, testimonials, advertisements, the physical form of the product (such as capsules, tablets, or injections), and even the specific target audience addressed in marketing communications. In other words, authorities consider not only what is claimed, but also how, where, and to whom those claims are communicated.
If a product is presented as preventing, curing, or treating diseases, it will exceed the permitted cosmetic scope under the ASEAN Cosmetic Directive — even when its formulation fully complies with ingredient requirements. For instance, a topical cream packaged in pharmaceutical-style blister packs or marketed toward individuals suffering from specific medical conditions may trigger regulatory scrutiny and possible reclassification. For this reason, cosmetic advertising compliance in ASEAN demands close coordination between legal, regulatory, and marketing teams to ensure that every aspect of product presentation remains firmly within cosmetic boundaries.
The final step considers the product’s physiological effect. While cosmetics may influence bodily functions, their effects are typically temporary and reversible. Continuous use is required to maintain results.
Claims that suggest permanent structural change, metabolic alteration, or medical intervention fall outside cosmetic boundaries.
As a guiding principle, claims that align with the Illustrative List of Cosmetic Products under Annex 1 of the ACD are generally considered acceptable in nature.
The ASEAN Cosmetic Claim Guidelines provide clear examples of claims that exceed the permitted cosmetic scope. These examples illustrate how certain wording can shift a product from cosmetic positioning into medicinal territory, potentially triggering reclassification and stricter regulatory control.
The table below summarizes common unacceptable claims by product category:
| Product Type | Unacceptable Claims (Illustrative Examples) |
|---|---|
| Hair Care Products | • Eliminates dandruff permanently • Restores hair cells • Hair loss can be arrested or reversed • Stimulates hair growth |
| Depilatories | • Stops, retards, or prevents hair growth |
| Nail Products | • Claims referring to nail growth resulting from nourishment |
| Skin Care Products | • Prevents, reduces, or reverses physiological changes caused by aging • Removes scars • Numbing effect • Prevents, heals, treats, or stops acne • Treatment of cellulite • Lose centimetres • Reduces or controls swelling/oedema • Removes or burns fat • Fungicidal action • Virucidal action |
| Oral or Dental Hygiene Products | • Treatment or prevention of dental abscess, gumboils, inflammation, mouth ulcers, periodontitis, pyorrhoea, periodontal disease, stomatitis, thrush, or other oral diseases/infections • Whitens tetracycline-induced stains |
| Deodorants & Anti-Perspirants | • Completely prevents sweating or perspiration |
| Perfumes / Fragrances / Colognes | • Aphrodisiac effect or hormonal attraction |
These examples illustrate a core regulatory boundary: cosmetic products must not claim to prevent, treat, cure, or alter disease conditions, nor should they imply permanent structural or metabolic changes. Claims suggesting pharmacological, immunological, or systemic action are likely to reclassify the product outside the cosmetic category.
One of the most practical insights from the ASEAN Cosmetic Claim Guidelines is the concept of “softening” claims. By adjusting wording to emphasize cosmetic effect rather than functional cure, brands can remain compliant while preserving marketing impact.
For example:
“Eliminates oil completely” becomes “Helps reduce excess oil.”
“Treats acne” becomes “Helps reduce the appearance of blemishes.”
“Stops sweating permanently” becomes “Provides long-lasting freshness.”
This linguistic precision is essential for cosmetic labeling requirements in ASEAN and reduces regulatory risk during product notification.
Failure to comply with ASEAN cosmetic claim standards may result in product notification rejection, administrative penalties, product recall, or reputational damage.
As ASEAN markets continue to grow in consumer demand and regulatory sophistication, authorities are placing increasing emphasis on truthful advertising and scientific substantiation.
For companies expanding into Southeast Asia, proactive compliance with the ASEAN Cosmetic Claim Guidelines ensures:
Smooth ASEAN cosmetic product registration
Reduced reclassification risk
Stronger brand credibility
Sustainable regional expansion
At Green NRJ, we support businesses in navigating ASEAN cosmetic notification, claims review, labeling compliance, and cross-border regulatory strategy to ensure seamless market entry.
The ASEAN Cosmetic Claim Guidelines provide a structured and legally grounded framework for determining whether a product qualifies as a cosmetic and which claims are permissible. By understanding the 5-step decision process — from composition to physiological effects — businesses can avoid costly regulatory pitfalls and maintain full compliance under the ASEAN Cosmetic Directive.
If your company is preparing to enter ASEAN markets, early claim review and regulatory alignment are essential. Contact Green NRJ today to secure compliant cosmetic product registration and confidently expand across Southeast Asia.